Hiroshi Moritake
Overview
Explore the profile of Hiroshi Moritake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fauzi Y, Nakahata S, Shimoda K, Matsuura T, Hagiwara S, Inoue K, et al.
Biochem Biophys Res Commun
. 2025 Mar;
756:151564.
PMID: 40086360
Previously, we developed a complete human IgG TFR1 antibody (JST-TFR09/PPMX-T003) that showed a potentially practical therapeutic effect against adult T-cell leukemia/lymphoma (ATLL) in vitro and in vivo. In the present...
2.
Aoki Y, Kota Y, Shimada M, Taniguchi T, Yamauchi S, Matsusaka M, et al.
Children (Basel)
. 2025 Feb;
12(2).
PMID: 40003248
Preterm infants often have unstable vital signs and prolonged hospital stays that can hinder parent-infant bonding, especially under COVID-19 restrictions. This study aimed to evaluate whether listening to songs recorded...
3.
Yonaga R, Kodama Y, Takamura K, Harada M, Moritake H
Cureus
. 2024 Nov;
16(10):e72078.
PMID: 39575017
In infants, anomalous vessels from the aortic arch are often diagnosed as patent ductus arteriosus or bronchial arteries. We present the case of a 22-day-old female with trisomy 21, found...
4.
Nagasawa S, Nishimura T, Yamada A, Kamimura S, Ishimura M, Moritake H
Hum Genome Var
. 2024 Nov;
11(1):41.
PMID: 39572557
We describe a case of RAS-associated autoimmune leukoproliferative disease with primary ciliary dyskinesia (PCD)-like symptoms, such as recurrent pneumonia, sinusitis, and otitis media, that occurred 7 years after hematopoietic cell...
5.
HDAC Inhibitors Induce HLA Class I Molecules through the SOX10-IRF1 Axis in Clear Cell Sarcoma Cells
Nguyen M, Kikuchi R, Nishibu S, Zhou Y, Moritake H, Nakamura T, et al.
Biol Pharm Bull
. 2024 Nov;
47(11):1913-1919.
PMID: 39567011
Although immune checkpoint inhibitors (ICIs) are an effective treatment for clear cell sarcoma (CCS), a rare melanocytic sarcoma with a poor prognosis, their efficacies are still limited. Therefore, a novel...
6.
Inoue Y, Shikada T, Moritake H
Opt Lett
. 2024 Nov;
49(21):6081-6084.
PMID: 39485417
Previous studies have demonstrated the refraction-type liquid crystal (LC)-based beam-steering devices within the visible wavelength range. However, these devices require substantial improvements in a steering angle for practical application. In...
7.
Moritake H
Rinsho Ketsueki
. 2024 Oct;
65(9):928-936.
PMID: 39358292
Acute myeloid leukemia (AML) accounts for approximately 25% of pediatric leukemia cases in Japan, with approximately 150 patients being newly diagnosed with AML annually. Pediatric acute myeloid leukemia is classified...
8.
Kinoshita M, Saito Y, Otani K, Uehara Y, Nagasawa S, Nakagawa M, et al.
Int J Hematol
. 2024 Sep;
120(5):601-612.
PMID: 39283580
Acute myeloid leukemia (AML) cells are highly dependent on oxidative phosphorylation and the mitochondrial dynamics regulated by fusion-related genes MFN1, MFN2, and OPA1 and fission-related genes DNM1L and MFF. An...
9.
Kato S, Nakashima K, Yamato G, Saito S, Taneyama Y, Yamamoto N, et al.
Pediatr Blood Cancer
. 2024 Aug;
71(10):e31244.
PMID: 39099137
Hypomethylating agent treatment for myeloid leukemia associated with Down syndrome (ML-DS) has been scarcely reported. Herein, we collected information on azacitidine treatment for ML-DS in Japan. Forty-eight cycles of azacitidine...
10.
Arima M, Inoue H, Misumi A, Tsukamoto S, Matsushita I, Araki S, et al.
Jpn J Ophthalmol
. 2024 Jul;
68(5):490-499.
PMID: 39060675
Purpose: To assess the safety and efficacy of ripasudil for retinopathy of prematurity (ROP). Study Design: Phase 1/2, multicenter, open-label, single-arm, 12-week clinical trial. Methods: Infants born with gestational age...